2024
M81 Examining the Relationship of Concurrent Obesity and Tobacco Use Disorder on the Development of Substance Use Disorders and Psychiatric Conditions: Findings From the NESARC-III
Fields L, Roberts W, Schwing I, McCoy M, McKee S. M81 Examining the Relationship of Concurrent Obesity and Tobacco Use Disorder on the Development of Substance Use Disorders and Psychiatric Conditions: Findings From the NESARC-III. Drug And Alcohol Dependence 2024, 260: 110361. DOI: 10.1016/j.drugalcdep.2023.110361.Peer-Reviewed Original Research
2023
Examining the relationship of concurrent obesity and tobacco use disorder on the development of substance use disorders and psychiatric conditions: Findings from the NESARC-III
Fields L, Roberts W, Schwing I, McCoy M, Verplaetse T, Peltier M, Carretta R, Zakiniaeiz Y, Rosenheck R, McKee S. Examining the relationship of concurrent obesity and tobacco use disorder on the development of substance use disorders and psychiatric conditions: Findings from the NESARC-III. Drug And Alcohol Dependence Reports 2023, 7: 100162. PMID: 37159814, PMCID: PMC10163607, DOI: 10.1016/j.dadr.2023.100162.Peer-Reviewed Original ResearchTobacco use disorderSubstance use disordersBody mass indexUse disordersPsychiatric conditionsRisk of SUDAdditional substance use disordersSingle health conditionsRelated Conditions Wave IIIWorse health outcomesNational Epidemiological SurveyPsychiatric disorder diagnosisHarmful substance useDSM-5 criteriaConcurrent obesityComorbid obesityMass indexSUD diagnosisRisk factorsObesityComorbid diagnosesEpidemiological surveyHealth outcomesNESARC-IIIDisorder diagnosis
2020
Co-occurring opioid and sedative use disorder: Gender differences in use patterns and psychiatric co-morbidities in the United States
Ellis JD, Pittman BP, McKee SA. Co-occurring opioid and sedative use disorder: Gender differences in use patterns and psychiatric co-morbidities in the United States. Journal Of Substance Use And Addiction Treatment 2020, 114: 108012. PMID: 32527509, PMCID: PMC7292885, DOI: 10.1016/j.jsat.2020.108012.Peer-Reviewed Original ResearchConceptsSedative use disorderOpioid use disorderUse disordersCo-occurring opioid use disorderMeeting criteriaPsychiatric conditionsCurrent opioid use disorderCo-occurring opioidPersonality disorderRisk of overdoseLogistic regression analysisCo-occurring symptomsImplementation of treatmentPosttraumatic stress disorderSchizotypal personality disorderAntisocial personality disorderNon-medical useBaseline characteristicsDepressive disorderGender-stratified logistic regression analysesPrescription monitoringOwn prescriptionsOpioidsStress disorderNESARC-III